ArticleJournal of clinical laboratory analysis2025

Nucleocapsid Antibodies as an Optimal Serological Marker of SARS-CoV-2 Infection: A Longitudinal Study at the Thomayer University Hospital.

Markéta Ibrahimová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.